Physician-guided. Personalized. Monitored.
Medication can be a powerful tool for weight loss, but it works best when it is part of a complete medical plan.
At Rochester Medical Weight Loss, Dr. Rachel Conley builds a personalized strategy that may include medication alongside nutrition planning, body composition monitoring, and ongoing accountability.
Medication decisions are guided by medical history, goals, and safety factors.
FDA-approved medication options may be considered when clinically appropriate.
Progress, side effects, nutrition, and body composition are monitored over time.
Medication is paired with real-life nutrition strategy, not treated as the whole plan.
What it is
Medication-assisted weight loss means using prescription medication, when appropriate, as one part of a physician-guided obesity treatment plan. The medication may help support appetite control, fullness, cravings, or metabolic response, but it does not replace the need for medical evaluation, nutrition support, and follow-up.
At Rochester Medical Weight Loss, the goal is not a one-time online prescription. The goal is safer, more personalized care that helps you understand what your body needs and how to maintain progress over time.
Medical baseline first
Obesity is a complex chronic disease. Medication can help, but it should not start with a quick "buy now" injection.
A physician-guided plan begins by understanding your health, your risks, your goals, and how your body is responding over time.
Your medical history, physical exam, blood pressure, and other baseline factors help guide safe care.
Labs may help identify metabolic, hormonal, or safety factors that affect medication choice.
InBody analysis helps track fat, muscle, and water so progress is measured beyond the scale.
Start here
If GLP-1 medication may be part of your plan, education matters. These pages explain what to expect, how common medication options differ, and why proper prescribing and monitoring matter.
Learn how appointments, dose changes, side effects, nutrition, and progress tracking may work.
Read MoreUnderstand how these medications differ and why the right choice depends on the patient.
Read MoreReview why medication source, quality, dosing, and FDA approval status matter for safety.
Read MoreGet answers to common questions about safety, expectations, insurance, and follow-up care.
Read MoreSafety matters
Some online sellers market compounded or unapproved semaglutide and tirzepatide products as if they are the same as FDA-approved medications.
FDA has warned that unapproved GLP-1 products do not go through FDA review for safety, effectiveness, or quality before being marketed. FDA has also warned about dosing errors with compounded injectable semaglutide, including overdoses that required medical attention or hospitalization.
At Rochester Medical Weight Loss, medication decisions are paired with in-person monitoring, careful dosing and titration, side effect management, and verified pharmacy channels.
Support beyond the prescription
Medication works best when the rest of the plan supports it. Your program may include whole-food meal planning, New Direction® meal replacements, nutrition education, behavior support, strength training guidance, movement support, and regular accountability visits.
Progress is monitored beyond the number on the scale, with attention to body composition, energy, side effects, nutrition adequacy, and long-term maintenance.
How it works
Medication-assisted weight loss starts with medical context, then continues with follow-up and adjustments based on how your body responds.
Step 1
Start with your goals and history.
We begin with a conversation about your medical background, weight history, goals, and what has or has not worked before.
Step 2
So we are not guessing.
Your baseline may include exam findings, vitals, bloodwork when appropriate, and body composition analysis.
Step 3
The medication should fit the patient.
If medication is appropriate, Dr. Conley selects the option and dosing approach that fits your clinical picture.
Step 4
Your plan can change as your body changes.
Your response, side effects, nutrition, and body composition are monitored over time.
Step 5
The goal is long-term support.
Medication is paired with nutrition, behavior strategy, accountability, and maintenance planning.
Common questions
Medication can be helpful for the right patient, but it should be chosen thoughtfully and monitored carefully.
No. Medication is only one possible tool. Dr. Conley reviews your medical history, goals, safety factors, and readiness before deciding whether medication belongs in your plan.
GLP-1 medications are FDA-approved for specific patients and indications, but all medications have risks and possible side effects. Medical supervision helps determine whether they are appropriate and how to monitor them safely.
Often, yes. Depending on your goals and medical history, medication may be paired with a whole-food plan, New Direction® meal replacements, or another nutrition strategy.
FDA has warned about unapproved GLP-1 products, compounded products, dosing errors, and products sold online under misleading claims. This is one reason Rochester Medical Weight Loss emphasizes physician guidance, verified pharmacy channels, and careful follow-up.
Coverage varies by medication, diagnosis, insurance plan, and pharmacy benefit rules. The office can help you understand next steps, but insurance approval is not guaranteed.
Learn more
Learn why medical context and in-person care can matter when medication is involved.
Read BlogUnderstand why obesity treatment is more complex than a simple online prescription.
Read BlogSee why physician training, monitoring, and multiple treatment tools matter in obesity care.
Read BlogMedication may be one tool in your plan, but the best care starts with understanding your body, your health history, and your long-term goals.
Medical weight loss treatment is individualized. This information is educational and is not a substitute for medical advice from your own clinician. Results vary, and no specific outcome is guaranteed.
